APOE and Alzheimer disease: AD patients carrying APOE4 variants displayed elevation of ceramides d18:1/18:0 and d18:1/24:1 in the gray matter of the middle frontal gyrus (MFG) and of ceramide d18:1/22:0 in the white matter of the MFG when compared to AD patients carrying APOE3.